Latest Anz Market News

Page 3 of 4
City Chic Collective has reversed its fortunes with a $15 million EBITDA turnaround in FY25, driven by strategic restructuring and strong ANZ growth. The company eyes a debt-free 2025 close and cash flow positivity in FY26 amid cautious optimism for US market expansion.
Logan Eniac
Logan Eniac
13 Nov 2025
City Chic Collective reports solid revenue growth driven by a 10% increase in ANZ sales and a resilient, profitable US business despite tariff challenges.
Logan Eniac
Logan Eniac
4 Nov 2025
RMA Global Limited kicked off FY26 with a robust 21% increase in recurring revenue, driven by the rollout of Curated Social and a strategic pivot to target US brokerages exclusively. The company’s new Social Studio platform is gaining traction across the US, Australia, and New Zealand.
Sophie Babbage
Sophie Babbage
31 Oct 2025
Orthocell has appointed MontsMed as the exclusive distributor for its nerve repair product Remplir™ in Hong Kong, marking a significant step in its Asian commercialisation strategy. This move opens access to the vast Guangdong-Hong Kong-Macao Greater Bay Area, complementing existing operations in Singapore and planned expansion in Thailand.
Ada Torres
Ada Torres
29 Oct 2025
Algorae Pharmaceuticals has signed a binding term sheet with India’s Cadila Pharmaceuticals to introduce two generic medicines targeting cardiovascular and metabolic disorders in Australia and New Zealand.
Ada Torres
Ada Torres
20 Oct 2025
Zip Co Limited has reported a near doubling in cash earnings for Q1 FY26, driven by robust transaction growth and improved operating leverage, particularly in the US market. The company also doubled its share buy-back program and raised its US transaction volume growth guidance.
Claire Turing
Claire Turing
20 Oct 2025
EROAD pivots strategically to prioritise ANZ electronic road user charging opportunities, revises FY26 guidance downward, and appoints John Scott as Executive Chair to steer growth.
Sophie Babbage
Sophie Babbage
17 Oct 2025
Algorae Pharmaceuticals has secured an exclusive licensing agreement with Sakar Healthcare to introduce five generic oncology medicines in Australia and New Zealand, marking its first commercial foray in the region.
Victor Sage
Victor Sage
23 Sept 2025
Pureprofile Limited reported a record FY25 with net profit after tax surging to $1.5 million, underpinned by 19% revenue growth and strategic AI product launches. The company’s global footprint expanded significantly, with international markets now accounting for nearly half of total revenue.
Sophie Babbage
Sophie Babbage
28 Aug 2025
City Chic Collective has reversed an $8.4 million EBITDA loss from FY24 to post a $6.4 million profit in FY25, driven by strong sales growth and disciplined cost management. The retailer plans to expand its store footprint and expects positive cash flow in FY26 amid improving market conditions.
Logan Eniac
Logan Eniac
28 Aug 2025
Zip Co has delivered a standout FY25 with cash earnings soaring 147%, driven by rapid US market expansion. The company is now considering a Nasdaq dual listing to fuel further growth.
Claire Turing
Claire Turing
22 Aug 2025
RMA Global Limited has reported its first full year of positive operating cash flow alongside accelerating revenue growth in both the US and ANZ markets, driven by strategic product launches and expanded brokerage partnerships.
Sophie Babbage
Sophie Babbage
31 July 2025

Browse the archive

Full archive